Effects of rosiglitazone on bone in postmenopausal diabetic women

Trial Profile

Effects of rosiglitazone on bone in postmenopausal diabetic women

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2011

At a glance

  • Drugs Rosiglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Jan 2011 Two-year follow-up results have been published (Clinical Endocrinology 73:305-312, 01 Sep 2010)
    • 21 Sep 2007 Results reported at EASD 2007.
    • 12 Apr 2007 The expected completion date for this trial is now 1 Mar 2006.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top